AgeX Therapeutics Inc. [AMEX:AGE] is seeing significant action in the Healthcare space. AGE stock has price per sales of 16.78. The company is also booking -0.31 earnings per share.
Over the last two 52 weeks, the company is trading -52.84%, while the S&P 500 is trading 0.55%.
The Price is right
Holding a Market Cap of $31.87 million, AgeX Therapeutics Inc. has seen a trading range over the last year of $0.67-$2.24.
For the last five days, AGE is up from its last closing price. The average shares trading hands each day is 455.95K, with average 10-day volume coming in at 0.48 million.
Using a Force Index Indicator is a good way to look at how strong actual buying and selling pressure is for AGE. When we apply the Elder Force Index to AgeX Therapeutics Inc., we are seeing an Elder Force Indicator number of 453130491.06.
Recent Performance
The company’s enterprise value has gone from $37.27M to $34.62M quarter-over-quarter. Obviously, the company is heading in the wrong direction, but there are still opportunities for growth in the sector.
In the last quarter, AGE made a profit of 0.38 million. AgeX Therapeutics Inc. also saw quarter revenue growth year over year of 23.78%. In addition, the company has operating cash flow of -$9.09 million.
Technical Analysis
Looking at popular technical indicators, the company’s 5-day moving average is 1.3820 compared to the 50-day moving average of 0.8692. So, we are clearly seeing an upward trajectory here.
The Relative Strength Index or RSI is an indicator ranging between 0 and 100 that traders use to determine if a stock is “overbought” or “oversold.” A strong uptrend tending to reach into the “overbought” status is above 70, while a downward trend will stay around the 30 mark. AGE currently holds a 9-day RSI of 97.55%, while 100-day RSI stands at 63.84%.
Another indicator we believe is worth keeping tabs on is the Moving Average Convergence Divergence or MACD. Similar to the concept of the Force Index — on the basis of price momentum — the MACD gives traders a tool to measure the turning point of a stock even during rapid fluctuations in price. Buy and sell signals are determined by a stock’s relation to the zero line, so if a stock is above a zero line for many weeks it might be a “buy.” On the other hand, if a stock is below the zero line consistently, it might be one to stay away from. Also, if the MACD line reaches a peak and dips, its momentum may be waning. AGE’s 9-day MACD is 0.6399 and the company’s 100-day MACD stands at 0.7755.
Inside Moves
Another area that is important to analyze is insider moves and majority shareholders. While this is not always an error-free way to tell what the future holds for a stock, you can maybe gather important information from reading the tea leaves about who is buying and selling.
The major holders for this stock are 44.02% by insiders and 24.58% by institutions. Regarding institutional holdings, Broadwood Capital, Inc. owns 7.95%, while the second top holder, Vanguard Group, Inc. (The), currently owns 1.71%.
